BMSSC
BSX icon

B. Metzler seel. Sohn & Co’s Boston Scientific BSX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2M Buy
333,583
+68,450
+26% +$3.72M 0.12% 90
2026
Q1 		$16.6M Buy
265,133
+26,456
+11% +$2.12M 0.15% 80
2025
Q4 		$22.8M Buy
238,677
+5,358
+2% +$525K 0.2% 68
2025
Q3 		$22.8M Buy
233,319
+2,765
+1% +$286K 0.2% 66
2025
Q2 		$24.8M Buy
230,554
+1,160
+0.5% +$117K 0.24% 62
2025
Q1 		$23.1M Buy
229,394
+3,683
+2% +$371K 0.24% 63
2024
Q4 		$20.2M Sell
225,711
-59,979
-21% -$5.28M 0.21% 68
2024
Q3 		$23.9M Buy
285,690
+10,771
+4% +$849K 0.24% 66
2024
Q2 		$21.2M Buy
274,919
+21,989
+9% +$1.61M 0.2% 65
2024
Q1 		$17.3M Sell
252,930
-12,514
-5% -$805K 0.19% 69
2023
Q4 		$15.3M Buy
265,444
+96,613
+57% +$5.16M 0.2% 67
2023
Q3 		$8.91M Sell
168,831
-6,298
-4% -$330K 0.13% 97
2023
Q2 		$9.47M Sell
175,129
-7,177
-4% -$375K 0.13% 109
2023
Q1 		$9.12M Buy
182,306
+37,553
+26% +$1.77M 0.14% 101
2022
Q4 		$6.7M Buy
144,753
+39,410
+37% +$1.71M 0.11% 125
2022
Q3 		$4.08M Sell
105,343
-35,476
-25% -$1.42M 0.07% 175
2022
Q2 		$5.25M Buy
140,819
+4,633
+3% +$189K 0.09% 156
2022
Q1 		$6.03M Sell
136,186
-2,423
-2% -$105K 0.08% 160
2021
Q4 		$5.96M Buy
138,609
+34,685
+33% +$1.46M 0.08% 162
2021
Q3 		$4.51M Buy
103,924
+19,803
+24% +$876K 0.07% 177
2021
Q2 		$3.6M Sell
84,121
-2,704
-3% -$114K 0.05% 203
2021
Q1 		$3.36M Sell
86,825
-950
-1% -$36K 0.06% 206
2020
Q4 		$3.13M Buy
+87,775
New +$3.16M 0.06% 193

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

B. Metzler seel. Sohn & Co's BSX Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Boston Scientific (BSX) stake by 26% in Q2 2026, buying an estimated $3.72M and bringing the position to 333,583 shares worth $14.2M. The position accounts for 0.12% of the portfolio, ranked #90.

B. Metzler seel. Sohn & Co first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $24.8M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 333,583 shares of Boston Scientific worth $14.2M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 68,450 Boston Scientific shares in Q2 2026, an estimated $3.72M.
  • Boston Scientific made up 0.12% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #90 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Boston Scientific position peaked at $24.8M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.